Search
Search
{{#data.error.root_cause}}
{{/data.error}}
{{^data.error}}
{{#texts.summary}}
[{{{type}}}] {{{reason}}}
{{/data.error.root_cause}}{{texts.summary}} {{#options.result.rssIcon}} RSS {{/options.result.rssIcon}}
{{/texts.summary}} {{#data.hits.hits}}
{{#_source.featured}}
FEATURED
{{/_source.featured}}
{{#_source.showImage}}
{{#_source.image}}
{{/_source.image}}
{{/_source.showImage}}
{{/data.hits.hits}}
{{{_source.title}}} {{#_source.showPrice}} {{{_source.displayPrice}}} {{/_source.showPrice}}
{{#_source.showLink}} {{/_source.showLink}} {{#_source.showDate}}{{{_source.displayDate}}}
{{/_source.showDate}}{{{_source.description}}}
{{#_source.additionalInfo}}{{#_source.additionalFields}} {{#title}} {{{label}}}: {{{title}}} {{/title}} {{/_source.additionalFields}}
{{/_source.additionalInfo}}Anti-Cytochrome P450 3A7 [F19P2H2]
(Cat#: 151864)
Description
| Cat# | 151864 |
| Applications | ELISA, IHC, WB |
| Antigen/Gene or Protein Targets | CYP3A7- Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (P450-HFLA) |
| Reactivity | Human |
| Relevance | This monoclonal antibody (MAb), when used in conjunction with the Mab specific to CYP3A5 clone F18 P3 B6, is able to differentiate between the CYP450 family 3 members: CYP3A5 and CYP3A7 |
| Host | Mouse |
| Immunogen | Ovalbumin-conjugated synthetic peptide ESRDETVSGA (C-terminal sequence) |
| Positive Control |
IHC: formalin-fixed, paraffin-embedded prostate cancer sections. Western blot: recombinant P450. Negative control: Gentest Cat. No M101b. |
| Subclass | IgG1 kappa |
| Strain | Balb/c |
| Research Area | Cancer, Cardiovascular, Cell Signaling & Signal Transduction, Metabolism |
| References |
CYP3A isoforms in Ewing's sarcoma tumors: an immunohistochemical study with clinical correlation. Europe PMC ID: 25670065 Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers. Europe PMC ID: 16243809 Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis. Europe PMC ID: 15897573 |
Image: Immunohistochemistry: antibody staining of prostate cancer tissue.
For Research Use Only.
